JP2005500368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500368A5 JP2005500368A5 JP2003518529A JP2003518529A JP2005500368A5 JP 2005500368 A5 JP2005500368 A5 JP 2005500368A5 JP 2003518529 A JP2003518529 A JP 2003518529A JP 2003518529 A JP2003518529 A JP 2003518529A JP 2005500368 A5 JP2005500368 A5 JP 2005500368A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- propylamino
- tetrahydro
- benzothiazole
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FASDKYOPVNHBLU-UHFFFAOYSA-N N6-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C(NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-UHFFFAOYSA-N 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 3
- 239000013543 active substance Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 claims 2
- 229940025084 amphetamine Drugs 0.000 claims 2
- 230000006735 deficit Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 239000000150 Sympathomimetic Substances 0.000 claims 1
- 239000000935 antidepressant agent Substances 0.000 claims 1
- 229940005513 antidepressants Drugs 0.000 claims 1
- 229960002430 atomoxetine Drugs 0.000 claims 1
- VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 claims 1
- 229960001058 bupropion Drugs 0.000 claims 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 claims 1
- 229960003914 desipramine Drugs 0.000 claims 1
- 229960004801 imipramine Drugs 0.000 claims 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 229960001252 methamphetamine Drugs 0.000 claims 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 claims 1
- 229960001344 methylphenidate Drugs 0.000 claims 1
- 229960001165 modafinil Drugs 0.000 claims 1
- 229960000761 pemoline Drugs 0.000 claims 1
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10137633A DE10137633A1 (de) | 2001-08-03 | 2001-08-03 | Pramipexol zur Behandlung von ADHD |
| PCT/EP2002/008500 WO2003013520A1 (de) | 2001-08-03 | 2002-07-31 | Pramipexol zur behandlung von adhd |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005500368A JP2005500368A (ja) | 2005-01-06 |
| JP2005500368A5 true JP2005500368A5 (https=) | 2006-01-05 |
Family
ID=7693957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003518529A Pending JP2005500368A (ja) | 2001-08-03 | 2002-07-31 | Ａｄｈｄ治療用プラミペクソール |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1416930A1 (https=) |
| JP (1) | JP2005500368A (https=) |
| AR (1) | AR035273A1 (https=) |
| CA (1) | CA2453485A1 (https=) |
| DE (1) | DE10137633A1 (https=) |
| MX (1) | MXPA04001001A (https=) |
| UY (1) | UY27408A1 (https=) |
| WO (1) | WO2003013520A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200906997A1 (tr) | 2009-09-11 | 2011-03-21 | Sanovel �La� San. Ve T�C. A. �. | Pramipeksol farmasötik bileşimleri. |
| TR200907554A1 (tr) * | 2009-10-06 | 2011-04-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Oral yolla dağılan pramıpexole bileşimleri. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5621133A (en) * | 1989-05-31 | 1997-04-15 | Deninno; Michael P. | Dopamine agonists |
| US7049337B2 (en) * | 2000-05-19 | 2006-05-23 | Wayne State University | Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential CNS receptor activity and behavior |
| US20020016334A1 (en) * | 2000-07-31 | 2002-02-07 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
-
2001
- 2001-08-03 DE DE10137633A patent/DE10137633A1/de not_active Withdrawn
-
2002
- 2002-07-31 JP JP2003518529A patent/JP2005500368A/ja active Pending
- 2002-07-31 WO PCT/EP2002/008500 patent/WO2003013520A1/de not_active Ceased
- 2002-07-31 CA CA002453485A patent/CA2453485A1/en not_active Abandoned
- 2002-07-31 EP EP02762417A patent/EP1416930A1/de not_active Withdrawn
- 2002-07-31 MX MXPA04001001A patent/MXPA04001001A/es not_active Application Discontinuation
- 2002-08-02 UY UY27408A patent/UY27408A1/es not_active Application Discontinuation
- 2002-08-02 AR ARP020102946A patent/AR035273A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1691811B1 (en) | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression | |
| US20190231772A1 (en) | Treatments for depression and other diseases with a low dose agent | |
| ES2788548T3 (es) | Tapentadol para la prevención y el tratamiento de la depresión y la ansiedad | |
| JP2008524332A (ja) | 睡眠傷害のための医薬組成物 | |
| CA2641917A1 (en) | Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin | |
| WO2006125042A1 (en) | Method for the treatment of drug-induced sexual dysfunction | |
| JP2009543780A (ja) | 制御放出製剤およびキット | |
| JP2010512413A5 (https=) | ||
| JP2009541443A5 (https=) | ||
| US9238033B2 (en) | Pharmaceutical composition containing KW-6002 and fluoxetine or paroxentine | |
| WO1999059593A1 (en) | Combination therapy for treatment of depression | |
| AU2002345024B2 (en) | Tablet comprising cetirizine and pseudoephedrine | |
| JP2024524434A (ja) | うつ状態を処置するための方法 | |
| JP2005508872A5 (https=) | ||
| TW200843763A (en) | 5-HTP combination therapy | |
| JP2022506113A5 (https=) | ||
| HUE034155T2 (en) | Therapeutic uses of 1- [2- (2,4-dimethylphenylsulfanyl) phenyl] piperazine | |
| JP2005500368A5 (https=) | ||
| CZ291864B6 (cs) | Léčivo pro léčení přírůstku hmotnosti | |
| JP2005533791A5 (https=) | ||
| JP2025500344A5 (https=) | ||
| HUP9903375A2 (hu) | Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények | |
| WO2005067909A1 (en) | Combination therapy with mecamylamine for the treatment of mood disorders | |
| US20080226714A1 (en) | Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-ht1a receptor having enhanced intestinal dissolution | |
| JP2004508333A5 (https=) |